EU office upholds antisense drug patent (PharmaBiz)

EU office upholds antisense drug patent (PharmaBiz)
Isis Pharmaceuticals Inc. has announced that in oral proceedings earlier this month, the European Patent Office (EPO) technical board of appeal reinstated with amended claims the Isis-owned Patent EP0618925 (the ’925 Patent).